Cara Therapeutics, Inc. (0HTC.L)
USD 0.25
(-1.15%)
USD 0.25
(-1.15%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 20.96 Million | 41.86 Million | 23.02 Million | 135.08 Million | 19.88 Million | 13.46 Million |
| Cost of Revenue | 6.17 Million | 7.26 Million | 1.55 Million | 107.07 Million | 113.16 Million | 75.53 Million |
| Gross Profit | 14.79 Million | 34.6 Million | 21.47 Million | 28.01 Million | -93.27 Million | -62.06 Million |
| Operating Expenses | 142.46 Million | 122.13 Million | 112.11 Million | 129.69 Million | 131.56 Million | 90.85 Million |
| Selling, General and Administrative Expenses | 27.64 Million | 30.25 Million | 29.41 Million | 21.74 Million | 17.74 Million | 15.32 Million |
| Research and Development Expenses | 108.51 Million | 91.87 Million | 82.7 Million | 107.85 Million | 113.82 Million | 75.53 Million |
| Other Expenses | 130 Thousand | 2.06 Million | 642 Thousand | 97 Thousand | 4.49 Million | 2.98 Million |
| Cost and Expenses | 142.46 Million | 129.4 Million | 112.11 Million | 129.69 Million | 131.56 Million | 90.85 Million |
| Operating Income | -121.49 Million | -87.53 Million | -89.08 Million | 5.38 Million | -111.67 Million | -77.38 Million |
| Interest Expense | 604 Thousand | - | - | - | - | - |
| Income Tax Expense | - | -2.06 Million | -248 Thousand | -691 Thousand | -816 Thousand | -389 Thousand |
| Earnings before Tax | -118.51 Million | -85.47 Million | -88.44 Million | 7.71 Million | -107.18 Million | -74.4 Million |
| Net Income | -118.51 Million | -83.41 Million | -88.19 Million | 8.41 Million | -106.37 Million | -74.01 Million |
| Earnings Per Share Basic | -2.19 | -1.55 | -1.74 | 0.18 | -2.49 | -2.06 |
| Earnings Per Share Diluted | -2.19 | -1.55 | -1.74 | 0.18 | -2.49 | -2.06 |
| Weighted Average Shares Outstanding | 54.14 Million | 53.65 Million | 50.71 Million | 47.41 Million | 42.66 Million | 35.89 Million |
| Weighted Average Shares Outstanding (Diluted) | 54.14 Million | 53.65 Million | 50.71 Million | 47.91 Million | 42.66 Million | 35.89 Million |
| Gross Margin | 0.71 | 0.83 | 0.93 | 0.21 | -4.69 | -4.61 |
| EBIT Margin | -5.61 | -2.09 | -3.87 | 0.04 | -5.62 | -5.75 |
| Profit Margin | -5.65 | -1.99 | -3.83 | 0.06 | -5.35 | -5.50 |
| EBITDA | -117.65 Million | -83.8 Million | -88.19 Million | 5.59 Million | -111.48 Million | -77.01 Million |
| Earnings Before Tax Margin | -5.79 | -2.09 | -3.87 | 0.04 | -5.62 | -5.75 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 991 Thousand | 2.13 Million | 3 Million | 20.96 Million | 4.86 Million | 6.93 Million |
| Cost of Revenue | 77 Thousand | 662 Thousand | 690 Thousand | 6.43 Million | 1.55 Million | 1.41 Million |
| Gross Profit | 914 Thousand | 1.47 Million | 2.31 Million | 14.53 Million | 3.3 Million | 5.51 Million |
| Operating Expenses | 17.12 Million | 28.73 Million | 34.92 Million | 136.03 Million | 33.76 Million | 37.85 Million |
| Selling, General and Administrative Expenses | 6.36 Million | 6.78 Million | 6.54 Million | - | 6.75 Million | 7.51 Million |
| Research and Development Expenses | 9.27 Million | 21.95 Million | 28.37 Million | - | 25.45 Million | 30.31 Million |
| Other Expenses | -1.48 Million | 952 Thousand | 874 Thousand | 3.58 Million | 1.55 Million | 861 Thousand |
| Cost and Expenses | 17.2 Million | 29.4 Million | 35.61 Million | 142.46 Million | 33.76 Million | 39.27 Million |
| Operating Income | -16.21 Million | -27.26 Million | -32.6 Million | -121.49 Million | -28.03 Million | -32.34 Million |
| Interest Expense | 1.91 Million | 1.98 Million | 604 Thousand | 604 Thousand | - | - |
| Income Tax Expense | - | -1276.00 | -1.00 | 91.1 Thousand | 807 Thousand | -62.08 Thousand |
| Earnings before Tax | -20.01 Million | -30.69 Million | -32.33 Million | -118.51 Million | -28.03 Million | -31.47 Million |
| Net Income | -20.01 Million | -30.69 Million | -32.33 Million | -118.51 Million | -28.03 Million | -31.47 Million |
| Earnings Per Share Basic | -0.37 | -0.56 | -0.59 | - | -0.52 | -0.58 |
| Earnings Per Share Diluted | -0.37 | -0.56 | -0.59 | - | -0.52 | -0.58 |
| Weighted Average Shares Outstanding | 54.72 Million | 54.58 Million | 54.47 Million | 54.14 Million | 54.23 Million | 54 Million |
| Weighted Average Shares Outstanding (Diluted) | 54.72 Million | 54.58 Million | 54.47 Million | 54.14 Million | 54.23 Million | 54 Million |
| Gross Margin | 0.92 | 0.69 | 0.77 | 0.69 | 0.68 | 0.80 |
| EBIT Margin | -16.28 | -12.75 | -10.83 | - | -5.76 | -4.66 |
| Profit Margin | -20.20 | -14.38 | -10.76 | -5.65 | -5.76 | -4.54 |
| EBITDA | -16.13 Million | -27.22 Million | -32.52 Million | - | -28.03 Million | -32.28 Million |
| Earnings Before Tax Margin | -16.36 | -12.77 | -10.85 | -5.79 | -5.76 | -4.66 |
UHAL-B
1999
ALPCV
4987
NHMAF
SNPHF